Combined oral contraceptive pills function primarily by suppressing ovulation through hormonal feedback.
the verdict
SUPPORTED
the evidence backs this
refutedsupported
the weight of evidence
2 sources for · 0 against
Peer-reviewed medical literature and reference sources confirm that combined oral contraceptive pills function primarily by inhibiting ovulation through hormonal feedback mechanisms that suppress gonadotropins.
The combined oral contraceptive. A practical guide. Prescribing the combined oral contraceptive pill is a rewarding combination of hands-on clinical medicine, logical therapeutics, prevention, and patient education. Lowest dose with the least side-effects is the overriding principle of prescribing. It is important to spend time teaching patients and partners how to manage their pill-taking and to be responsible for their medication and prevention follow up. Low does pills have an effectiveness of 0.2-1.0 pregnancies/100 woman-years. The pill functions by multiple modes of action, namely: inhibition of ovulation by suppressing cyclic follicle stimulating hormone and luteinising hormone release; reducing sperm penetrability of cervical mucus; rendering the endometrium hostile to implantation; and probably affecting tubal transit time. Patients will no longer have their 'periods' but will experience hormone withdrawal bleeds. The greatest risk of ovulation is at the end of the pill-free week, not in the middle of the pack.
Combined oral contraceptive pills were developed to prevent ovulation by suppressing the release of gonadotropins. Combined hormonal contraceptives,
The combined oral contraceptive pill (COCP), often referred to as the birth control pill or colloquially as "the pill", is a type of birth control that is designed to be taken orally by women. It is the oral form of combined hormonal contraception. The pill contains two important hormones: a progestin (a synthetic form of the hormone progestogen/progesterone) and estrogen (usually ethinylestradiol
The…
Hormonal oral contraceptives are preventive medications taken orally by females to avoid pregnancy by manipulating their sex hormones. The first oral contraceptive was approved by the US Food and Drug Administration (FDA) and sold to the market in 1960. There are two types of hormonal oral contraceptives, namely combined oral contraceptives and progesterone-only pills. Oral contraceptives, whether combined or progesterone-only, can effectively prevent pregnancy by regulating hormonal changes in the menstrual cycle, inhibiting ovulation, and altering cervical mucus to impede sperm mobility; combined pills have extra effects in menstrual cycle regulation and menstrual pain relief. Common off-label uses include menstrual suppression and acne relief, with combined oral contraceptives having additional benefits in relieving menstrual migraines.
Some researchers question a causal link between combined oral contraceptive pill use and decreased libido; a 2007 study of 1700 women found combined oral contraceptive pill users experienced no change in sexual satisfaction. A 2005 laboratory study of genital arousal tested fourteen women before and after they began taking combined oral contraceptive pills. The study found that women experienced a significantly wider range of arousal responses after beginning pill use; decreases and increases in measures of arousal were equally common.
In 2012, The Journal of Sexual Medicine published a review of research studying the effects of hormonal contraceptives on female sexual function that concluded that the sexual side effects of hormonal contraceptives are not well-studied and especially in regards to impacts on libido, with research establishing only mixed effects where only small percentages of women report experiencing an increase or decrease and majorities report being unaffected. In 2013, The European Journal of Contraception & Reproductive Health Care published a review of 36 studies including 8,422 female subjects in total taking combined oral contraceptive pills that found that 5,358 subjects (or 63.6 percent) reported no change in libido, 1,826 subjects (or 21.7 percent) reported an increase, and 1,238 subjects (or 14.7…
Everything we examined (2)
This check searched the claim as stated. It did not run a separate search for evidence against it.